Biomedical subjects
John Simons
Publications and source records attributed to John Simons.
Therapy that gets inside your head--literally.
Explore the source record for details and available documents.
A new CEO'S RX for what ails Merck.
Explore the source record for details and available documents.
The quest for custom cures.
Explore the source record for details and available documents.
Doesn't anyone know how to run a drug company?
Explore the source record for details and available documents.
Blowing the whistle at the FDA.
Explore the source record for details and available documents.
Ten tech trends. Genetic medicine's next big step.
Explore the source record for details and available documents.
Ways to beat the drug bust. Pharma stocks are down for good reasons, but that doesn't mean they're all bad bets.
Explore the source record for details and available documents.
Will Merck survive Vioxx?
Explore the source record for details and available documents.
Statins could be the next aspirin.
Explore the source record for details and available documents.
Not for the faint of heart. Boston Scientific's stent recall is a blow to earnings--but an opportunity for investors.
Explore the source record for details and available documents.
Lilly goes off Prozac.
Explore the source record for details and available documents.
Merck's man in the hot seat.
Explore the source record for details and available documents.
The perfect mix for your portfolio.
Explore the source record for details and available documents.
Why do drug companies fear this man?
Explore the source record for details and available documents.
You'll lose sleep over this pill.
Explore the source record for details and available documents.
Is it too late to save Schering?
Explore the source record for details and available documents.